Kwang Soo Cheong
Corporate Officer/Principal bei Carey Business School
Profil
Kwang Soo Cheong is currently an Associate Professor at Carey Business School since 2005.
He previously worked as an Independent Director at Rexahn Pharmaceuticals, Inc. He also served as an Assistant Professor-Economics at the University of Hawai'i at Hilo from 1994 to 2001.
Dr. Cheong holds a doctorate degree from Stanford University and has completed his undergraduate and graduate studies at Seoul National University.
Aktive Positionen von Kwang Soo Cheong
| Unternehmen | Position | Beginn |
|---|---|---|
| Carey Business School | Corporate Officer/Principal | 01.01.2001 |
Ehemalige bekannte Positionen von Kwang Soo Cheong
| Unternehmen | Position | Ende |
|---|---|---|
University of Hawai'i at Hilo
 University of Hawai'i at Hilo Other Consumer ServicesConsumer Services University of Hawai'i at Hilo engages in the provision of services relating to higher education. It offers bachelor’s degrees, minors, master’s degrees, doctoral degrees, certificate programs, graduate certificate programs, and distance learning. The company was founded in 1947 and is headquartered in Hilo, HI. | Corporate Officer/Principal | 01.01.2001 |
| REXAHN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kwang Soo Cheong
| Seoul National University | Graduate Degree |
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
